Gilead (GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention treatment lenacapavir ...

With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...

With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...

"China market is one of the most attractive markets for Edwards," said Leo Tam, senior director of the business unit of Transcatheter Aortic Valve Replacement, Edwards Lifesciences China, citing a lot ...

Illumina, a United States-headquartered company specializing in DNA sequencing and array-based technologies, is showcasing ...

The earnings season for the drug/biotech sector is now in its final lap, with some large biotech and generic drug companies ...

The Supreme Court of California is gearing up to decide an important question for the future of product liability law: Do drug manufacturers have ...

New Delhi: The PHD Chamber of Commerce and Industry (PHDCCI) and the Association of Indian Medical Devices (AiMed), in alliance with the Manufacturers of Imaging, Therapy and Radiology Devices ...

Life Sciences, Medical Sciences and Population Health Sciences - at our November in-person Postgraduate Open Evening. UCL is ranked among the top ten in the world and winner of the Times and Sunday ...

With the data in hand, Arcus’ chief medical ... Gilead hires Arcus CMO Grossman, putting him in charge of cancer pact with his former biotech Under an existing collaboration pact, Gilead ...

STAT+ subscribers can sign up here to get it delivered to their inbox. The next referendum on Gilead Sciences’ oft-criticized oncology business is approaching. Circle Nov. 5 on your calendars.